Insmed, Inc. (INSM)
111.12
+2.53
(+2.33%)
USD |
NASDAQ |
Oct 02, 16:00
111.44
+0.32
(+0.29%)
After-Hours: 20:00
Insmed Price to Book Value : 32.02 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 32.02 |
| October 01, 2026 | 31.29 |
| September 30, 2026 | 32.89 |
| September 29, 2026 | 33.32 |
| September 28, 2026 | 33.91 |
| September 25, 2026 | 33.95 |
| September 24, 2026 | 35.03 |
| September 23, 2026 | 34.10 |
| September 22, 2026 | 34.82 |
| September 21, 2026 | 34.87 |
| September 18, 2026 | 34.58 |
| September 17, 2026 | 35.73 |
| September 16, 2026 | 35.32 |
| September 15, 2026 | 34.56 |
| September 14, 2026 | 36.11 |
| September 11, 2026 | 37.29 |
| September 10, 2026 | 36.68 |
| September 09, 2026 | 37.12 |
| September 08, 2026 | 35.99 |
| September 04, 2026 | 36.39 |
| September 03, 2026 | 36.50 |
| September 02, 2026 | 36.49 |
| September 01, 2026 | 35.01 |
| August 31, 2026 | 35.10 |
| August 28, 2026 | 34.16 |
| Date | Value |
|---|---|
| August 27, 2026 | 34.98 |
| August 26, 2026 | 35.84 |
| August 25, 2026 | 35.70 |
| August 24, 2026 | 35.73 |
| August 21, 2026 | 36.24 |
| August 20, 2026 | 36.04 |
| August 19, 2026 | 37.65 |
| August 18, 2026 | 37.02 |
| August 17, 2026 | 36.98 |
| August 14, 2026 | 35.66 |
| August 13, 2026 | 36.40 |
| August 12, 2026 | 38.12 |
| August 11, 2026 | 38.20 |
| August 10, 2026 | 38.83 |
| August 07, 2026 | 37.78 |
| August 06, 2026 | 38.20 |
| August 05, 2026 | 28.53 |
| August 04, 2026 | 28.46 |
| August 03, 2026 | 28.37 |
| July 31, 2026 | 28.41 |
| July 30, 2026 | 29.25 |
| July 29, 2026 | 29.72 |
| July 28, 2026 | 30.01 |
| July 27, 2026 | 30.18 |
| July 24, 2026 | 30.81 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Biogen, Inc. | 1.723 |
| Gilead Sciences, Inc. | 15.18 |
| United Therapeutics Corp. | 3.612 |
| Vertex Pharmaceuticals, Inc. | 6.315 |
Price to Book Value Related Metrics
| PS Ratio | 20.96 |
| Price | 111.12 |
| Earnings Yield | -3.69% |
| Market Cap | 24.26B |